INNOVATE (NYSE:VATE) Announces Quarterly Earnings Results, Beats Estimates By $3.28 EPS

INNOVATE (NYSE:VATE) released its earnings results on Thursday. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of ($2.18) by $3.28, FiscalAI reports. The company had revenue of $495.50 million for the quarter, compared to analysts’ expectations of $251.70 million.

Here are the key takeaways from INNOVATE’s conference call:

• INNOVATE reported third-quarter revenue of $495.5 million and adjusted EBITDA of $40.5 million, up from $347.1 million and $19.8 million a year earlier; net income attributable to common and participating preferred stockholders was $15.8 million. The improvement was driven primarily by infrastructure, especially DBM Global, whose results benefited from higher activity and project efficiencies.
• The company completed the sale of DBM Global after quarter-end, receiving approximately $413 million in cash and retaining an ownership interest in IES Holdings; it also sold a controlling interest in broadcasting while keeping a 25% stake and an option to increase it. INNOVATE said it used DBM sale proceeds to repay its corporate credit line and redeem $325 million of senior secured notes, reducing principal indebtedness from $583.3 million to $238.3 million.
• MediBeacon reported progress toward broader adoption of its TGFR System, reimbursement initiatives, and U.S. validation studies for a wireless sensor; it also secured orders for 600 monitors in China, with shipments planned from late 2026 through the second quarter of 2027. Management cautioned that conversion of commercial interest may take six to 12 months, and initial pharmaceutical clinical-trial use is anticipated in 2027.
• R2 cited worldwide demand of 3.1 million, but recognized only $1.2 million in quarterly revenue, and life sciences revenue overall fell 61.3% year over year to $1.2 million. R2 said manufacturing is expanding, with 116 systems carried into the fourth quarter representing roughly $1.9 million of potential future revenue, but converting demand into sales remains a key execution challenge.

INNOVATE Trading Down 0.3%

INNOVATE stock traded down $0.01 during mid-day trading on Friday, hitting $4.84. The stock had a trading volume of 20,018 shares, compared to its average volume of 149,705. The firm has a market capitalization of $66.09 million, a P/E ratio of -2.61 and a beta of 2.57. The firm’s 50 day moving average is $6.59 and its 200 day moving average is $8.86. INNOVATE has a one year low of $3.75 and a one year high of $21.30.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on VATE. Wall Street Zen cut INNOVATE from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of INNOVATE in a research note on Wednesday. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

About INNOVATE

INNOVATE Corp. is a diversified holding company that owns and operates businesses in infrastructure, life sciences and broadcasting. The company was formerly known as HC2 Holdings and adopted the INNOVATE name in 2021. Its infrastructure operations include DBM Global, which provides steel construction, fabrication and related industrial services for projects such as commercial buildings, bridges and industrial facilities. These services are delivered in the United States and select international markets.